NEW YORK, April 15 (GenomeWeb News) - Abbott Laboratories will distribute additional molecular diagnostic tests from Artus, the companies said yesterday.
Under the expanded agreement, Abbott will offer all real-time-PCR-based diagnostic tests developed by Artus of Hamburg, Germany, that run on Applied Biosystems instruments. These include tests for hepatitis B virus, Epstein Barr virus, Varicella Zoster virus, Parvo B19 virus, cytomegalovirus, herpes simplex virus, and enterovirus.
Abbott already distributes Artus' tests for SARS, Chlamydia trachomatis, and Mycobacterium tuberculosis, as well as other assays on the ABI platform. Abbott markets these test through an exclusive alliance with Celera Diagnostics.